Literature DB >> 7724491

Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.

K Shiotani1, K Uehata, T Irie, K Uekama, D O Thompson, V J Stella.   

Abstract

The hemolytic activity of beta-cyclodextrin (beta-CyD) on rabbit erythrocytes was reduced by the introduction of negatively-charged groups onto the hydroxyls of beta-CyD; the membrane disrupting abilities decreased in the order of beta-CyD > 2-hydroxypropyl-beta-CyD (HP-beta-CyD) > sulfobutyl-beta-CyD (SB-beta-CyD) >> beta-CyD sulfate (S-beta-CyD). Under pre-hemolytic concentrations, both beta-CyD and SB-beta-CyD induced shape changes of membrane invagination on the erythrocytes. In sharp contrast, S-beta-CyD showed biphasic effect on the shape of the erythrocytes; i.e. the crenation at relatively low concentrations and the invagination at higher concentrations. The S-beta-CyD-induced membrane crenation arose from a direct action on the membranes rather than cell metabolism-mediated effects. Unlike beta-CyD, S-beta-CyD was found to bind to the erythrocytes and may be confined to the outer surface of the membrane bilayer, which may expand the exterior layer relative to the cytoplasmic half, thereby inducing the cells to crenate. On the other hand, the membrane invagination mediated by the three beta-CyDs was initiated by extracting specific membrane lipids from the cells, depending upon their inclusion abilities, subsequently leading to the lysis of the cells. These results indicate that SB-beta-CyD and S-beta-CyD interact with the erythrocyte membranes in a differential manner and possess lower membrane disrupting abilities than the parent beta-CyD and HP-beta-CyD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724491     DOI: 10.1023/a:1016238720701

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Sulfation and hemolytic activity of cyclodextrin.

Authors:  E J Macarak; K Kumor; P B Weisz
Journal:  Biochem Pharmacol       Date:  1991-09-12       Impact factor: 5.858

2.  A spin-label study of the correlation between stomatocyte formation and membrane fluidization of erythrocytes.

Authors:  S Noji; T Takahashi; H Kon
Journal:  Biochem Pharmacol       Date:  1982-10-15       Impact factor: 5.858

3.  [Comparison of the effects of drugs on K+ efflux through the membrane of human erythrocytes and on the membrane shape (author's transl)].

Authors:  T Sato; M Ikeda; Y Kanaho; T Fujii
Journal:  Yakugaku Zasshi       Date:  1981-12       Impact factor: 0.302

4.  The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

Authors:  H W Frijlink; A C Eissens; N R Hefting; K Poelstra; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

5.  Effect of polyanions on the unfolding of acidic fibroblast growth factor.

Authors:  C J Burke; D B Volkin; H Mach; C R Middaugh
Journal:  Biochemistry       Date:  1993-06-29       Impact factor: 3.162

6.  Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats.

Authors:  A Gerloczy; T Hoshino; J Pitha
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

7.  Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions.

Authors:  M P Sheetz; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

8.  Characterization of sulphoalkyl ether derivatives of beta-cyclodextrin by capillary electrophoresis with indirect UV detection.

Authors:  R J Tait; D J Skanchy; D P Thompson; N C Chetwyn; D A Dunshee; R A Rajewski; V J Stella; J F Stobaugh
Journal:  J Pharm Biomed Anal       Date:  1992-09       Impact factor: 3.935

9.  Membrane bilayer balance and erythrocyte shape: a quantitative assessment.

Authors:  J E Ferrell; K J Lee; W H Huestis
Journal:  Biochemistry       Date:  1985-06-04       Impact factor: 3.162

10.  Protective effects of cyclodextrin sulphates against gentamicin-induced nephrotoxicity in the rat.

Authors:  K Uekama; K Shiotami; T Irie; Y Ishimaru; J Pitha
Journal:  J Pharm Pharmacol       Date:  1993-08       Impact factor: 3.765

View more
  4 in total

1.  The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins.

Authors:  K Okimoto; R A Rajewski; K Uekama; J A Jona; V J Stella
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

Review 2.  Cyclodextrins: their future in drug formulation and delivery.

Authors:  V J Stella; R A Rajewski
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

3.  Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.

Authors:  K Okimoto; M Miyake; N Ohnishi; R A Rajewski; V J Stella; T Irie; K Uekama
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 4.  Interactions between cyclodextrins and cellular components: Towards greener medical applications?

Authors:  Loïc Leclercq
Journal:  Beilstein J Org Chem       Date:  2016-12-07       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.